Picture of Cryosite logo

CTE Cryosite Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapHigh Flyer

Momentum

Relative Strength (%)
1m+8.91%
3m-0.36%
6m+14.65%
1yr+110.48%
Volume Change (%)
10d/3m-86.43%
Price vs... (%)
52w High-13.79%
50d MA+7.45%
200d MA+31.16%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value19.67
Price to Tang. Book19.8
Price to Free Cashflow22.05
Price to Sales3.11
EV to EBITDA13.08

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital10.64%
Return on Equity121.85%
Operating Margin16.09%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202330th Jun 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Cryosite EPS forecast chart

Profile Summary

Cryosite Limited is engaged in providing outsourced clinical trials logistic services. The Company manages the entire clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management. Its segments include Clinical Trials, Biological Storage and Logistics, and Cord Blood and Tissue Storage. The Clinical Trials, Biological Storage and Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport solutions and biological storage to the clinical trials, research and pharmaceutical industry. The Cord Blood and Tissue Storage segment provides long term storage for cord blood and tissue samples. Its clients include the medical, pharmaceutical, veterinary and biotechnology industries.

Directors

Last Annual
June 30th, 2022
Last Interim
June 30th, 2022
Incorporated
December 14th, 1999
Public Since
May 9th, 2002
No. of Employees
34
Sector
Healthcare Providers & Services
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
48,809,563
Blurred out image of a map
Address
13a Ferndell St, South granville, SYDNEY, 2142
Web
https://cryosite.com
Phone
+61 288652000
Auditors
Mazars Risk & Assurance Pty Limited

CTE Share Price Performance

Upcoming Events for CTE

Half Year 2023 Cryosite Ltd Earnings Release

Similar to CTE

Picture of Althea group logo

Althea group

au flag iconAustralian Stock Exchange - SEATS

Picture of Apiam Animal Health logo

Apiam Animal Health

au flag iconAustralian Stock Exchange - SEATS

Picture of Artrya logo

Artrya

au flag iconAustralian Stock Exchange - SEATS

Picture of Asian American Medical logo

Asian American Medical

au flag iconAustralian Stock Exchange - SEATS

Picture of Australian Clinical Labs logo

Australian Clinical Labs

au flag iconAustralian Stock Exchange - SEATS

FAQ

Or unlock with your email

Or unlock with your email